Literature DB >> 12589777

Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK.

Rahul R Mohan1, Audrey E K Hutcheon, Rosan Choi, JongWook Hong, JongSoo Lee, Rajiv R Mohan, Renato Ambrósio, James D Zieske, Steven E Wilson.   

Abstract

The aim of this study was to semi-quantitatively analyze stromal cell apoptosis, stromal cell proliferation, and myofibroblast generation over time points from 4hr to 3 months in rabbit eyes having photorefractive keratectomy (PRK) or laser in situ keratomeliusis (LASIK). Stromal cell necrosis and inflammatory cell infiltration were also studied. PRK for low myopia (-4.5diopters [D]), PRK for high myopia (-9.0D), and LASIK for high myopia (-9.0D) were performed in rabbit eyes, and corneas were obtained for examination at 4, 24, and 72hr, 1 and 4 weeks, and 3 months after surgery. A total of 144 rabbits were included in the study. Stromal cell apoptosis, proliferation, and myofibroblast generation were evaluated semi-quantitatively by TUNEL assay, immunocytochemical analysis of Ki67, and immunocytochemical analysis of alpha-smooth muscle actin, respectively. Stromal cell necrosis and characteristics of other cell types in the stroma were evaluated by electron microscopy. Keratocyte apoptosis and the subsequent proliferation and generation of myofibroblasts were qualitatively and quantitatively different in PRK for high myopia compared to either PRK for low myopia or LASIK for high myopia. Stromal cell necrosis becomes a significant form of cell death by 24hr after injury and may involve corneal fibroblasts, myofibroblasts, and inflammatory cells. Large numbers of polymorphonuclear cells and monocytes invade the cornea by 24hr after surgery and persist for over 1 week. The qualitative and quantitative differences in the cellular wound healing response after PRK for high and low myopia and LASIK for high myopia are likely determinants of the clinical differences in refractive outcome and some of the complications, such as regression and haze, seen after these procedures.

Entities:  

Mesh:

Year:  2003        PMID: 12589777     DOI: 10.1016/s0014-4835(02)00251-8

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  130 in total

1.  Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits.

Authors:  M R Santhiago; V Singh; F L Barbosa; V Agrawal; S E Wilson
Journal:  Exp Eye Res       Date:  2011-09-14       Impact factor: 3.467

Review 2.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

3.  Efficacy and safety of mitomycin C as an agent to treat corneal scarring in horses using an in vitro model.

Authors:  Dylan G Buss; Ajay Sharma; Elizabeth A Giuliano; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2010-07       Impact factor: 1.644

Review 4.  Corneal wound healing.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2020-06-15       Impact factor: 3.467

5.  Cationic liposome-mediated bcl-xl gene transfection into human keratocytes.

Authors:  Lei Liu; Xinyu Li; Xuefei Zhu; Guigang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 6.  Biomechanics and wound healing in the cornea.

Authors:  William J Dupps; Steven E Wilson
Journal:  Exp Eye Res       Date:  2006-05-23       Impact factor: 3.467

7.  Keratocyte density in the retroablation area after LASEK for the correction of myopia.

Authors:  Wolfgang Artur Herrmann; Manuela Muecke; Michael Koller; Veit Peter Gabel; Chris Patrick Lohmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-06-01       Impact factor: 3.117

8.  Contrasting cellular damage after Blue-IRIS and Femto-LASIK in cat cornea.

Authors:  Kaitlin T Wozniak; Noah Elkins; Daniel R Brooks; Daniel E Savage; Scott MacRae; Jonathan D Ellis; Wayne H Knox; Krystel R Huxlin
Journal:  Exp Eye Res       Date:  2017-08-31       Impact factor: 3.467

9.  Plasma rich in growth factors (PRGF) for the promotion of bone cell proliferation and tissue regeneration.

Authors:  Matteo Brucoli; Roberta Sonzini; Michela Bosetti; Paolo Boffano; Arnaldo Benech
Journal:  Oral Maxillofac Surg       Date:  2018-08-04

Review 10.  Significance of lipid mediators in corneal injury and repair.

Authors:  Sachidananda Kenchegowda; Haydee E P Bazan
Journal:  J Lipid Res       Date:  2009-11-03       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.